RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
186 hedge funds and large institutions have $893M invested in Revance Therapeutics, Inc. in 2023 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 87 increasing their positions, 51 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
57% less capital invested
Capital invested by funds: $2.07B → $893M (-$1.18B)
60% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 43
Holders
186
Holding in Top 10
2
Calls
$15.9M
Puts
$12.5M
Top Buyers
| 1 | +$27.4M | |
| 2 | +$20.4M | |
| 3 | +$18.4M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$13.2M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$7.88M |
Top Sellers
| 1 | -$36.4M | |
| 2 | -$31.6M | |
| 3 | -$28.7M | |
| 4 |
Two Sigma Advisers
New York
|
-$28.4M |
| 5 |
Holocene Advisors
New York
|
-$21.3M |